Journal of Clinical Pediatrics >
Genetic and phenotypic analysis of five patients with GNAO1 gene related disorders
Received date: 2021-06-29
Online published: 2022-05-13
Objective To investigate the genotypes and phenotypes features of patients with GNAO1 gene variants. Methods Genetic features, clinical manifestations and therapeutic reaction of five patients with GNAO1 gene variants were retrospectively analyzed. Results A total of 5 patients with GNAO1 gene variants were detected, including 4 patients with missense variants and 1 with splice site variation. Three variants were reported previously and two were novel variants. Two children presented with early-onset infantile epileptic encephalopathy with varying degrees of dyskinesia; three children presented with extrapyramidal symptoms (two with dystonia and one with choreoathetosis) and no seizures for the time being; profound developmental delay was observed in all five patients. Two patients with epilepsy did not response to multiple antiepileptic drugs. Two patients with dystonia underwent deep brain stimulation (DBS) therapy. The BFMDRS score decreased by 32.36% one month after surgery in one patient. However, no significant improvement was found in the other patient, and the BFMDRS score decreased by only 7.79% at 12 months postoperatively. One patient with choreoathetosis intended to accept DBS treatment later. Conclusions The majority of GNAO1 gene variants were missense mutation. The clinical manifestations of patients with GNAO1 gene variants were various, mainly presenting with developmental delay, movement disorders, and/or epilepsy. The epilepsy and the extrapyramidal symptoms responded poorly to the medical therapy, and DBS treatment could alleviate the dyskinesia in some patients.
Haibo YANG , Yongxin WEN , Qingping ZHANG , Xinhua BAO . Genetic and phenotypic analysis of five patients with GNAO1 gene related disorders[J]. Journal of Clinical Pediatrics, 2022 , 40(5) : 361 -365 . DOI: 10.12372/jcp.2022.21e0985
| [1] | Feng H, Khalil S, Neubig RR, et al. A mechanistic review on GNAO1-associated movement disorder[J]. Neurobiol Dis, 2018, 116: 131-141. |
| [2] | Zamponi GW, Currie KP. Regulation of Ca(V)2 calcium channels by G protein coupled receptors[J]. Biochim Biophys Acta, 2013, 1828(7): 1629-1643. |
| [3] | Mayfield J, Blednov YA, Harris RA. Behavioral and genetic evidence for GIRK channels in the CNS: role in physiology, pathophysiology, and drug addiction[J]. Int Rev Neurobiol, 2015, 123: 279-313. |
| [4] | Nakamura K, Kodera H, Akita T, et al. De novo mutations in GNAO1, encoding a Galphao subunit of heterotrimeric G proteins, cause epileptic encephalopathy[J]. Am J Hum Genet, 2013, 93(3): 496-505. |
| [5] | Saitsu H, Fukai R, Ben-Zeev B, et al. Phenotypic spectrum of GNAO1 variants: epileptic encephalopathy to involuntary movements with severe developmental delay[J]. Eur J Hum Genet, 2016, 24(1): 129-134. |
| [6] | Kulkarni N, Tang S, Bhardwaj R, et al. Progressive movement disorder in brothers carrying a GNAO1 mutation responsive to deep brain stimulation[J]. J Child Neurol, 2016, 31(2): 211-214. |
| [7] | Feng H, Sjögren B, Karaj B, et al. Movement disorder in GNAO1 encephalopathy associated with gain-of-function mutations[J]. Neurology, 2017, 89(8): 762-770. |
| [8] | Koy A, Cirak S, Gonzalez V, et al. Deep brain stimulation is effective in pediatric patients with GNAO1 associated severe hyperkinesia[J]. J Neurol Sci, 2018, 391: 31-39. |
| [9] | Waak M, Mohammad SS, Coman D, et al. GNAO1-related movement disorder with life-threatening exacerbations: movement phenomenology and response to DBS[J]. J Neurol Neurosurg Psychiatry, 2018, 89(2): 221-222. |
| [10] | Ananth AL, Robichaux-Viehoever A, Kim YM, et al. Clinical course of six children with GNAO1 mutations causing a severe and distinctive movement disorder[J]. Pediatr Neurol, 2016, 59: 81-84. |
| [11] | Sakamoto S, Monden Y, Fukai R, et al. A case of severe movement disorder with GNAO1 mutation responsive to topiramate[J]. Brain Dev, 2017, 39(5): 439-443. |
| [12] | Yilmaz S, Turhan T, Ceylaner S, et al. Excellent response to deep brain stimulation in a young girl with GNAO1-related progressive choreoathetosis[J]. Childs Nerv Syst, 2016, 32(9): 1567-1568. |
| [13] | Danti FR, Galosi S, Romani M, et al. GNAO1encephalopathy: Broadening the phenotype and evaluating treatment and outcome[J]. Neurol Genet, 2017, 3(2): e143. |
| [14] | Honey CM, Malhotra AK, Tarailo-Graovac M, et al. GNAO1 mutation-induced pediatric dystonic storm rescue with pallidal deep brain stimulation[J]. J Child Neurol, 2018, 33(6): 413-416. |
| [15] | Benato A, Carecchio M, Burlina A, et al. Long-term effect of subthalamic and pallidal deep brain stimulation for status dystonicus in children with methylmalonic acidemia and GNAO1 mutation[J]. J Neural Transm (Vienna), 2019, 126(6): 739-757. |
| [16] | Yamashita Y, Ogawa T, Ogaki K, et al. Neuroimaging evaluation and successful treatment by using directional deep brain stimulation and levodopa in a patient with GNAO1-associated movement disorder: A case report[J]. J Neurol Sci, 2020, 411:116710. |
/
| 〈 |
|
〉 |
